Home › Acute Biphenotypic Leukemia › California › San Francisco
Acute Biphenotypic Leukemia clinical trials in San Francisco, CA
5 studies for Acute Biphenotypic Leukemia are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RecruitingPhase 2
- UCSF Medical Center-Mission Bay, San Francisco
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- UCSF Medical Center-Mission Bay, San Francisco
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- UCSF Medical Center-Mission Bay, San Francisco
Venetoclax Basket Trial for High Risk Hematologic Malignancies
RecruitingPhase 1
- University of California San Francisco-Benioff Children's Hospital, San Francisco
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- UCSF School of Medicine, San Francisco
Acute Biphenotypic Leukemia trials in other cities
- Seattle, WA15 studies
- Houston, TX11 studies
- New York City, NY10 studies
- Atlanta, GA8 studies
- Durham, NC8 studies
- Chicago, IL7 studies
- Memphis, TN7 studies
- Baldwin Park, CA6 studies
- Philadelphia, PA6 studies
- Los Angeles, CA6 studies
- Dallas, TX6 studies
- Charlotte, NC6 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer29 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Colorectal Cancer19 studies
- Cardiovascular Disease18 studies
- Ovarian Cancer18 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.